Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors
Authors:
Open Access
- 26 January 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (28) , 46491-46497
Abstract
The clinical characteristics of metastatic lung tumors are not well understood. To explore the surgical indications, surgical modes, and factors that influence postoperative outcomes, we analyzed clinical data from 42 patients with metastatic lung tumors who received surgical treatment at Tianjin Medical University Cancer Institute and Hospital between January 2000 and January 2014. Gender, age, nature of resections, surgical mode, smoking index, disease-free intervals (DFIs), number of metastatic lesions, and lymph node metastases were analyzed. Patients were followed for 6 to 98 months. We found that surgical treatment is feasible for resectable metastatic lung tumors, though postoperative radiochemotherapy had no significant effect on postoperative survival rates among patients with metastatic lung tumors. No patients died perioperatively. The 1-year, 3-year, and 5-year survival rates after surgical resection of metastatic lung tumors were 88.1%, 45.7%, and 34.6%, respectively. Univariate analysis indicated that DFIs and lymph node metastasis correlated with patient prognoses, while multivariate analysis indicated these two variables were independent prognostic factors. Thus surgical treatment may be indicated, depending on patients’ specific condition, to lengthen DFIs in patients with metastatic lung tumors with or without evident lymph node metastasis.Keywords
This publication has 22 references indexed in Scilit:
- Is Lymph Node Dissection Required in Pulmonary Metastasectomy for Colorectal Adenocarcinoma?The Annals of Thoracic Surgery, 2012
- Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancerThe Lancet Oncology, 2008
- Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2007
- Prognostic Factors and Survival after Pulmonary Resection of Metastatic Renal Cell CarcinomaEuropean Urology, 2005
- Benefits of surgery for patients with pulmonary metastases from colorectal carcinomaThe Annals of Thoracic Surgery, 2004
- Surgical resection of lung metastases from epithelial tumorsThe Annals of Thoracic Surgery, 2004
- Uncertain benefit from surgery in patients with lung metastases from breast carcinomaCancer, 2003
- Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Long-term results of lung metastasectomy: Prognostic analyses based on 5206 casesThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Pulmonary MetastasectomyChest, 1995